Inflammation as a New Therapeutic Target among Older Patients with Ischemic Heart Disease.

Cardiovascular (CV) diseases remain a global health challenge, with ischemic heart disease (IHD) being the primary cause of both morbidity and mortality. Despite optimal pharmacological therapy, older patients with IHD exhibit an increased susceptibility to recurrent ischemic events, significantly impacting their prognosis. Inflammation is intricately linked with the aging process and plays a pivotal role in the evolution of atherosclerosis. Emerging anti-inflammatory therapies have shown promise in reducing ischemic events among high-risk populations. This review aims to explore the potential of targeted anti-inflammatory interventions in improving clinical outcomes and the quality of life for older patients with IHD.

[The long and winding road of the clinical pharmacy in Chile]. / El largo y sinuoso camino de la farmacia clinica en Chile.

Clinical pharmacy is a health discipline in which pharmacists provide patient care that optimizes rational medication use and promotes health, wellness and disease prevention. The beginnings of clinical pharmacy in Chile were inspired by the origin in the School of Pharmacy of the University of California, San Francisco (UCSF), in the mid-1960s. However, the historical development in our country, both in teaching and in the professional field, was accompanied by difficulties and success, which became a long and winding road. This article shares the events that gave rise to its beginnings in Chile, first through teaching, then in pharmacovigilance and clinical pharmacokinetics, to later describe its professional expansion and recognition as a specialty of pharmacy. This article briefly recounts the history of the Chilean clinical pharmacy to this day. Some names of people or institutions were not mentioned. Therefore the authors apologize in advance to pharmacists and organizations whose contribution cannot be recognized in this way. However, we know that this specialty has not been forged only by the names that appear, but by all those who love and respect the work of the clinical pharmacy.

Sex-Related Differences in Heart Failure Diagnosis.

PURPOSE OF REVIEW: The literature on the importance of sex in heart failure diagnosis is scarce. This review aims to summarize current knowledge on sex differences regarding the diagnosis of heart failure. RECENT FINDINGS: Comorbidities are frequent in patients with heart failure, and their prevalence differs between sexes; some differences in symptomatology and diagnostic imaging techniques were also found. Biomarkers also usually show differences between sexes but are not significant enough to establish sex-specific ranges. This article outlines current information related to sex differences in HF diagnosis. Research in this field remains to be done. Maintaining a high diagnostic suspicion, actively searching for the disease, and considering the sex is relevant for early diagnosis and better prognosis. In addition, more studies with equal representation are needed.

The role of bioimpedance analysis in overweight and obese patients with acute heart failure: a pilot study.

AIMS: Residual congestion at the time of hospital discharge is an important readmission risk factor, and its detection with physical examination and usual diagnostic techniques have strong limitations in overweight and obese patients. New tools like bioelectrical impedance analysis (BIA) could help to determine when euvolaemia is reached. The aim of this study was to investigate the usefulness of BIA in management of heart failure (HF) in overweight and obese patients. METHODS AND RESULTS: Our study is a single-centre, single-blind, randomized controlled trial that included 48 overweight and obese patients admitted for acute HF. The study population was randomized into two arms: BIA-guided group and standard care. Serum electrolytes, kidney function, and natriuretic peptides were followed up during their hospital stay and at 90 days after discharge. The primary endpoint was development of severe acute kidney injury (AKI) defined as an increase in serum creatinine by >0.5 mg/dL during hospitalization, and the main secondary endpoint was the reduction of N-terminal pro-brain natriuretic peptide (NT-proBNP) levels during hospitalization and within 90 days after discharge. The BIA-guided group showed a remarkable lower incidence of severe AKI, although no significant differences were found (41.4% vs. 16.7%; P = 0.057). The proportion of patients who achieved levels of NT-proBNP < 1000 pg/mL at 90 days was significantly higher in the BIA-guided group than in the standard group (58.8% vs. 25%; P = 0.049). No differences were observed in the incidence of adverse outcomes at 90 days. CONCLUSIONS: Among overweight and obese patients with HF, BIA reduces NT-proBNP levels at 90 days compared with standard care. In addition, there is a trend towards lower incidence of AKI in the BIA-guided group. Although more studies are required, BIA could be a useful tool in decompensated HF management in overweight and obese patients.

The genus Syllis Savigny in Lamarck, 1881 (Annelida: Syllidae: Syllinae) from Australia (Part 3): new species and redescription of previously described species.

Syllis Savigny in Lamarck, 1818, the type genus of Syllidae, is the largest and most diverse within the family. This genus presents many taxonomic, biogeographic, and phylogenetic problems due mainly to the lack of molecular data and morphological synapomorphies for many of the species, but also due to poor or inadequate descriptions. In order to improve the knowledge of the genus, we have undertaken a morphological revision of Australian species, based on type material and material collected over years by the Australian Museum. This is the third paper dealing with this family. Eighteen species are herein described, of which five are new and twelve are redescriptions of already known species, with four new combinations: Syllis imajimai, n. sp.; S. narranuk, n. sp.; S. noolinga, n. sp.; S. similisunzima, n. sp.; S. thylacine, n. sp.; S. busseltonensis (Hartmann-Schröder, 1982) n. comb.; S. patriciae (Hartmann-Schröder, 1981) n. comb.; S. pharobroomensis (Hartmann-Schröder, 1979) n. comb., S. pharynxcircunfusata (Hartmann-Schröder, 1979) n. comb, S. armillaris (O. F. Müller, 1771); S. augeneri Haswell, 1920; S. benelihauae (Campoy & Alquézar, 1982); S. hyalina Grube, 1863; S. cf. nigrescens Grube, 1878; S. profunda Cognetti, 1955; S. truncata Haswell, 1920; and S. variegata Grube, 1860.

El largo y sinuoso camino de la farmacia clinica en Chile / The long and winding road of the clinical pharmacy in Chile

Clinical pharmacy is a health discipline in which pharmacists provide patient care that optimizes rational medication use and promotes health, wellness and disease prevention. The beginnings of clinical pharmacy in Chile were inspired by the origin in the School of Pharmacy of the University of California, San Francisco (UCSF), in the mid-1960s. However, the historical development in our country, both in teaching and in the professional field, was accompanied by difficulties and success, which became a long and winding road. This article shares the events that gave rise to its beginnings in Chile, first through teaching, then in pharmacovigilance and clinical pharmacokinetics, to later describe its professional expansion and recognition as a specialty of pharmacy. This article briefly recounts the history of the Chilean clinical pharmacy to this day. Some names of people or institutions were not mentioned. Therefore the authors apologize in advance to pharmacists and organizations whose contribution cannot be recognized in this way. However, we know that this specialty has not been forged only by the names that appear, but by all those who love and respect the work of the clinical pharmacy.

IgA nephropathy: an overview of drug treatments in clinical trials.

INTRODUCTION: IgA nephropathy (IgAN) is the commonest primary glomerulonephritis worldwide and may progress to end-stage kidney disease (ESKD) within a 10-20 year period. Its slowly progressive course has made clinical trials challenging to perform, however the acceptance of proteinuria reduction as a surrogate end point has significantly improved the feasibility of conducting clinical trials in IgAN, with several novel and repurposed therapies currently undergoing assessment. Already, interim results are demonstrating value to some of these, offering great hope to those with IgAN. AREAS COVERED: This review explores the rationale, candidates, clinical precedents, and trial status of therapies that are currently or have recently been evaluated for efficacy in IgAN. All IgAN trials registered with the U.S. National Library of Medicine; ClinicalTrials.gov were reviewed. EXPERT OPINION: For the first time, effective treatment options beyond supportive care are becoming available for those with IgAN. This is the culmination of commendable international efforts and signifies a new era for those with IgAN. As more therapies become available, future challenges will revolve around deciding which treatments are most appropriate for individual patients, which is likely to push IgAN into the realm of precision medicine.

Effects of Season on Donor and Recipient Cows and Calf Performance from Birth to Weaning in Embryo Transfer Programs in the Tropics.

The aim of this study was to assess the seasonal effect of an embryo transfer program in the tropics on the donor response, recipient reproductive performance and calf growth from birth to weaning. This study included five-year records from 145 donors, 1149 embryo transfers (ET) and 609 in calves. The effect of the season (dry or wet) was evaluated at the time of embryo flushing, embryo transfer and birth of the calves. There was a seasonal effect on the yield and quality of the embryos. The number of nonfertilized and transferable good quality embryos increased in the wet season. For the recipients, the probability of pregnancy after an ET decreased by 6% for each year of the dam's age. However, no seasonal effect was found when comparing ET calves with their control group (natural mating-NM), nevertheless, weaning weight was associated with birth body weight, treatment, sex of the calf, season at birth, year of treatment, and dam's age. Calves born by NM had lower average daily gain (ADG), and male calves registered higher gains than females. Likewise, calves born during the rainy season had lower ADG compared with calves born during the dry season. In conclusion, this study shows that seasonal effect is more apparent in donor and calf performance than in the recipients.

Tasa de ultrafiltración horaria ajustada a peso corporal y mortalidad en hemodiálisis / Ultrafiltration rate adjusted to body weight and mortality in hemodialysis patients

Antecedentes y objetivo: La mortalidad de los pacientes en hemodiálisis es alta. Una tasa de ultrafiltración horaria ajustada por peso (UFR/W) elevada se ha asociado con episodios de hipotensión arterial y con mayor riesgo de muerte y/o eventos cardiovasculares. Material y métodos: Hemos evaluado la asociación entre UFR/W y mortalidad en 215 pacientes en hemodiálisis prevalentes seguidos durante 28 ± 6,12 meses. Se estimaron características clínicas basales y UFR/W media a lo largo del seguimiento. Resultados: La UFR/W media fue 9,0 ± 2,4 y los terciles 7,1 y 10,1 mL/kg/h. Se categorizó a la población en función del tiempo que habían estado con UFR/W igual o superior a los puntos de corte descritos en la literatura como relacionados con mayor mortalidad (10,0 mL/kg/h y 13,0 mL/kg/h). Los pacientes con mayor UFR/W fueron más jóvenes, con mayor ganancia de peso interdiálisis y porcentaje de reducción de peso, pero con menor peso seco, inicial y final. Durante el seguimiento, fallecieron 46 (21,4%) personas de las cuales la mayoría eran > 70 años, diabéticas o con enfermedad cardiovascular. No hubo diferencias en la mortalidad entre los grupos de UFR/W ni en la UFR/W entre los fallecidos y no fallecidos. En comparación con estudios previos donde describieron la asociación entre UFR/W y mortalidad, en nuestra población había más prevalencia de medicación protectora cardiovascular y no se observaron UFR/W tan altas. Conclusión: En nuestro medio, la UFR/W más elevada se observó en pacientes más jóvenes y de menor peso y no se asoció con mayor mortalidad. (AU)

Background and aims: Mortality among hemodialysis patients remains high. An elevated ultrafiltration rate adjusted by weight (UFR/W) has been associated with hypotension and higher risk of death and/or cardiovascular events. Methods: We evaluated the association between UFR/W and mortality in 215 hemodialysis patients. The mean follow-up was 28 ± 6.12 months. We collected patientś baseline characteristics and mean UFR/W throughout the follow-up. Results: Mean UFR/W was 9.0 ± 2,4 and tertiles 7.1 y 10.1 mL/kg/h. We divided our population according to the percentage of sessions with UFR/W above the limits described in the literature associated with increased mortality (10.0 mL/kg/h and 13.0 mL/kg/h). Patients with higher UFR/W were younger, with higher interdialytic weight gain and weight reduction percentage but lower dry, pre and post dialysis weight. Throughout the follow-up, 46 (21.4%) patients died, the majority over 70 years old, diabetic or with cardiovascular disease. There were neither differences regarding mortality between groups nor differences in UFR/W among patients who died and those who did not. Contrary to previous studies, we did not find an association between UFR/W and mortality, maybe due to a higher prevalence in the use of cardiovascular protection drugs and lower UFR/W. Conclusions: The highest UFR/W were observed in younger patients with lower weight and were not associated with an increased mortality. (AU)

Near IR stationary wave Fourier transform lambda meter in lithium niobate: multiplexing and improving optical sampling using spatially shifted nanogroove antenna.

Several integrated optics solutions currently exist to develop monolithic, robust, and lightweight high-resolution spectrometers for spatial applications. An interesting option is generating a stationary wave inside a single-mode waveguide, and sampling the interference fringes using dielectric discontinuities on the surface of the waveguide. This allows the recording of the signal on a detector on top of the waveguide, and using dedicated Fourier transform methods to recover the spectrum of the source. All the difficulty is then linked to the length of the interferogram that is sampled. This determines the spectral resolution and the spacing between sampling centers, which are ultimately limited by the pixel pitch, and that will determine the spectral range of the spectrum. In addition, the dielectric discontinuities that will extract the flux from the waveguide have a relatively wide angular emission, resulting in crosstalk between pixels, and reducing the effective sampling step. Finally, the optical sensitivity of these systems is limited since the waveguides are single mode. Therefore, improving the efficiency of stationary wave Fourier transform spectrometers will require reducing the angular divergence of the sampled signal, reducing the sampling step, and increasing the optical input collection capacity. To achieve the two latest conditions, one interesting approach is spatial multiplexing. In this paper, we present the proof of concept of a multiplexed integrated optics Fourier transform spectrometer based on lithium niobate waveguides, using focused ion beam nanogrooves as sampling centers. The spatially shifted position of the antennas between consecutive waveguides will allow us to determine an unknown wavelength with tens of picometer resolution. The extraction efficiency and bandwidth of the antennas will be theoretically studied to optimize their periodicity and match a given pixel pitch. Finally, the ability to develop this concept on an electro-optic material will be of great interest to achieve further active phase modulation and increase the spectral bandwidth.

Automatic Ankle Angle Detection by Integrated RGB and Depth Camera System.

Depth cameras are developing widely. One of their main virtues is that, based on their data and by applying machine learning algorithms and techniques, it is possible to perform body tracking and make an accurate three-dimensional representation of body movement. Specifically, this paper will use the Kinect v2 device, which incorporates a random forest algorithm for 25 joints detection in the human body. However, although Kinect v2 is a powerful tool, there are circumstances in which the device's design does not allow the extraction of such data or the accuracy of the data is low, as is usually the case with foot position. We propose a method of acquiring this data in circumstances where the Kinect v2 device does not recognize the body when only the lower limbs are visible, improving the ankle angle's precision employing projection lines. Using a region-based convolutional neural network (Mask RCNN) for body recognition, raw data extraction for automatic ankle angle measurement has been achieved. All angles have been evaluated by inertial measurement units (IMUs) as gold standard. For the six tests carried out at different fixed distances between 0.5 and 4 m to the Kinect, we have obtained (mean ± SD) a Pearson's coefficient, r = 0.89 ± 0.04, a Spearman's coefficient, ρ = 0.83 ± 0.09, a root mean square error, RMSE = 10.7 ± 2.6 deg and a mean absolute error, MAE = 7.5 ± 1.8 deg. For the walking test, or variable distance test, we have obtained a Pearson's coefficient, r = 0.74, a Spearman's coefficient, ρ = 0.72, an RMSE = 6.4 deg and an MAE = 4.7 deg.

Treatment of steroid-refractory chronic graft-versus-host disease with imatinib: Real-life experience of the Spanish group of hematopoietic transplantation (GETH).

Treatment of steroid-refractory chronic graft-versus-host disease (cGVHD) is a challenge. Here, we describe a retrospective analysis of 66 patients with steroid-refractory cGVHD treated with imatinib (starting dose of 100 mg in 70% of patients; maximum dose of 100-200 mg in 74%). Most patients had multi-organ involvement (≥2 organs, 83%), with the most affected being skin (85%), oral mucosa (55%), eyes (42%), and lungs (33%). The overall response rate was 41% (21 partial and three complete responses). The organ with the best response rate was the skin (46%), followed by gastrointestinal tract (43%), liver (41%), the oral mucosa (36%), eyes (29%), and lungs (18%). Imatinib led to steroid tapering in 17/38 patients. Twenty-five (38%) patients experienced imatinib-related adverse events, comprising extra-hematologic toxicity (n = 24, 36%) and hematologic toxicity (n = 6, 9%). No cases of grade 4-5 toxicity were reported. The main causes of imatinib discontinuation were treatment failure (52%) and toxicity (9%). After a median follow-up of 41 months, the 3-year overall survival was 81%, with no difference between imatinib responders and non-responders. These real-life results show that imatinib is safe and has moderate efficacy in patients with heavily pre-treated cutaneous sclerotic cGVHD; however, activity against lung cGVHD is very limited.

Ultrafiltration rate adjusted to body weight and mortality in hemodialysis patients.

BACKGROUND AND AIMS: Mortality among hemodialysis patients remains high. An elevated ultrafiltration rate adjusted by weight (UFR/W) has been associated with hypotension and higher risk of death and/or cardiovascular events. METHODS: We evaluated the association between UFR/W and mortality in 215 hemodialysis patients. The mean follow-up was 28 ±â€¯6.12 months. We collected patients' baseline characteristics and mean UFR/W throughout the follow-up. RESULTS: Mean UFR/W was 9.0 ±â€¯2,4 and tertiles 7.1 y 10.1 mL/kg/h. We divided our population according to the percentage of sessions with UFR/W above the limits described in the literature associated with increased mortality (10.0 ml/kg/h and 13.0 mL/kg/h). Patients with higher UFR/W were younger, with higher interdialytic weight gain and weight reduction percentage but lower dry, pre and post dialysis weight. Throughout the follow-up, 46 (21.4%) patients died, the majority over 70 years old, diabetic or with cardiovascular disease. There were neither differences regarding mortality between groups nor differences in UFR/W among patients who died and those who did not. Contrary to previous studies, we did not find an association between UFR/W and mortality, maybe due to a higher prevalence in the use of cardiovascular protection drugs and lower UFR/W. CONCLUSIONS: The highest UFR/W were observed in younger patients with lower weight and were not associated with an increased mortality.

Three new species of Syllis Savigny in Lamarck, 1818 (Annelida, Syllidae) from Chilean Patagonia.

Three new species of the genus Syllis Savigny in Lamarck, 1818, from the Chilean Patagonia are described, figured and discussed. The specimens were collected in boulders, sediment bottoms, Macrocystis pyrifera holdfasts, and inside tubes of Chaetopterus cf. variopedatus. Syllis patagonica n. sp., is characterized by its color pattern, short, fusiform dorsal cirri, plenty of hyaline inclusions, acuminate posterior acicula, and compound chaetae with slightly bidentate falcigers. Syllis terraeignium n. sp., has similar compound chaetae, but dorsal cirri are longer than those of the above mentioned species, a long proventricle, and the posterior acicula are straight, pointed. Finally, Syllis patersoni n. sp., has a slender, elongated body, with moderately long dorsal cirri, plenty of hyaline inclusions, acuminate posterior acicula, and compound chaetae composed by falcigers and short spiniger-like.

Syllidae (Annelida) from East Timor and the Philippines (Pacific Ocean), with the description of three new species of Syllis Savigny in Lamarck, 1818.

East Timor is an island located to the south of the Indonesian Archipelago and to the north of Australia, between the Indian and Pacific Oceans. It is included in the Coral Triangle and houses an amazing quantity of marine biodiversity. However, only two species of Syllidae (Annelida) have been reported up to now: Trypanosyllis migueli and T. devae. Based on a small collection from the Australian Museum, we have identified nine genera and 17 species: Brevicirrosyllis mariae, Opisthodonta morena, Sphaerosyllis densopapillata, Branchiosyllis australis, B. exilis, B. maculata, B. verruculosa, Haplosyllis djiboutiensis, Opisthosyllis brunnea, Syllis alternata, S. broomensis, S. corallicola, S. erikae, S. gerlachi, S. hyalina, S. setoensis and Trypanosyllis luzonensis. This is the first record of S. gerlachi outside the Indian Ocean, and B. mariae, O. morena, S. densopapillata, H. djiboutiensis, S. corallicola and S. erikae have not been previously reported in tropical Asia. A specimen of Parahaplosyllis sp. could not be identified due to its poor condition. Three species belonging to Syllis are herein described as new: S. cambuk n. sp. has a large size body, with anterior segments much wider and shorter than posterior ones, long whip-shaped dorsal cirri and bidentate midbody and posterior chaetae, with both teeth equal in size and shape; Syllis hampirmenyatu n. sp. has three chaetae per posterior parapodium, with short and wide blades appearing to be fused with shafts, but still clearly distinguishable from each other, bidentate, with proximal tooth clearly smaller and thinner than distal one; and S. maganda n. sp. is easily recognizable because of its spectacular orange and blue colouration, only observable in living specimens, with broad transverse red stripes on the dorsum forming a distinctive pattern and red spots on the cirri and prostomium observable in both living and fixed specimens. Additionally, Philippine samples from the Museo Nacional de Ciencias Naturales of Madrid have been examined corresponding to S. maganda n. sp. A Philippine specimen of S. maganda n. sp. had a small unidentified specimen of Haplosyllis attached to a posterior dorsal cirrus, which is the first documented case of such an interaction between two species of Syllidae. This provisionally called Haplosyllis sp. is characterized by its simple chaetae with short spur and two very long, distinct curved teeth, very close to each other. A regenerated prostomium and a stolon were also found in other Philippine specimens of S. maganda n. sp.

New species and records of the genus Syllis Savigny in Lamarck, 1818 (Annelida: Syllidae) from Socotra Archipelago (Indian Ocean).

Based on a census of the polychaete fauna of the Socotra Archipelago in the Indian Ocean we report here new findings on the genus Syllis Savigny in Lamarck, 1818. These ten species are newly recorded from this area: Syllis alternata Moore, 1908; Syllis bouvieri Gravier, 1900; Syllis broomensis (Hartmann-Schröder, 1979); Syllis compacta Gravier, 1900; Syllis crassicirrata (Treadwell, 1925); Syllis gerlachi (Hartmann-Schröder, 1960); Syllis hyalina Grube, 1863; Syllis lutea (Hartmann-Schröder, 1960); Syllis schulzi (Hartmann-Schröder, 1960); Syllis ypsiloides Aguado, San Martín Ten Hove, 2008. Additionally, Syllis qamhiyn sp. nov. is described as a new species, characterized by its conspicuously thick and short dorsal cirri filled with a gelatinous substance and reduced number of compound chaetae from medium to posterior parapodia, with enlarged shafts and short blades which become almost unidentate and do not fuse with shafts. Following an examination of the holotype of S. bouvieri, its status as a valid species and not as synonym of Syllis prolifera Krohn, 1852, as considered by some authors (see Licher 1999) is confirmed, and a redescription is included.

The dirty little secret of urate-lowering therapy: useless to stop chronic kidney disease progression and may increase mortality.

Hyperuricaemia is frequent in chronic kidney disease (CKD). Observational studies have shown an association with adverse outcomes and acquired hyperuricaemia (meaning serum urate levels as low as 1.0 mg/dL) in animal models induces kidney injury. This evidence does not justify the widespread use of urate-lowering drugs for asymptomatic hyperuricaemia in CKD. However, promising results from small, open-label studies led some physicians to prescribe urate-lowering drugs to slow CKD progression. Two recent, large, placebo-controlled trials (CKD-FIX and PERL) showed no benefit from urate lowering with allopurinol on the primary endpoint of CKD progression, confirming prior negative results. Despite these negative findings, it was still argued that the study population could be optimized by enrolling younger non-proteinuric CKD patients with better preserved glomerular filtration rate (GFR). However, in these low-risk patients, GFR may be stable under placebo conditions. Additionally, the increased mortality trends already identified in gout trials of urate-lowering therapy were also observed in CKD-FIX and PERL, sending a strong safety signal: 21/449 (4.7%) and 10/444 (2.2%) patients died in the combined allopurinol and placebo groups, respectively [chi-squared P-value 0.048; relative risk 2.07 (95% CI 0.98-4.34); P = 0.06]. Given the absent evidence of benefit in multiple clinical trials and the potentially serious safety issues, the clear message should be that urate-lowering therapy should not be prescribed for the indication of slowing CKD progression. Additionally, regulatory agencies should urgently reassess the safety of chronic prescription of urate-lowering drugs for any indication.

A new species and nine new records of Syllidae (Annelida) from the Socotra Archipelago (Indian Ocean).

In this paper, we report 10 species of Syllidae, collected in the Socotra Archipelago (Indian Ocean). They belong to eight different genera in four subfamilies namely, Syllinae: Haplosyllis Langerhans, 1879, Megasyllis San Martín, Hutchings Aguado, 2008, Opisthosyllis Langerhans, 1879, Trypanosyllis Claparède, 1864; Eusyllinae: Eusyllis Malmgren, 1867, Odontosyllis Claparède, 1863; Exogoninae: Salvatoria McIntosh, 1885; and Autolytinae: Myrianida Milne Edwards, 1845. Trypanosyllis mercedesae n. sp., is here formally described and distinguished from congeners. Trypanosyllis richardi Gravier, 1900 is re-described, adding important taxonomic information to the original description, based on specimens collected from Djibouti (Gulf of Aden). We provide new insight into the reproduction of Megasyllis heterosetosa (Hartmann-Schröder, 1991) with the description of a specimen with an attached female dicerous stolon, full of oocytes. Odontosyllis polycera (Schmarda, 1861) is described because it is newly recorded for the Indian Ocean. We also provide some remarks about Myrianida pachycera (Augener, 1913), collected with a chain of stolons.

Improving the vertical radiation pattern issued from multiple nano-groove scattering centers acting as an antenna for future integrated optics Fourier transform spectrometers in the near IR.

The stationary wave integrated Fourier transform spectrometer (SWIFTS) is based on the sampling of a stationary wave using nano-scattering centers on the surface of a channel waveguide. Single nano-scale scattering centers above the waveguide surface will radiate the sampled signal with wide angular distribution, which is not compatible with the buried detection area of infrared (IR) detectors, resulting in crosstalk between pixels. An implementation of multiple diffraction nano-grooves (antenna) for each sampling center is proposed as an alternative solution to improve directivity towards the detector pixel by narrowing the scattering angle of the extracted light. Its efficiency is demonstrated from both simulated and measured far-field radiative patterns exhibiting a promising method to be used for the future integrated IR-SWIFTS.

Taxonomic contribution to the genus Sphaerosyllis (Annelida: Syllidae: Exogoninae) in the Black Sea.

During a study of fauna associated with a shallow-water Zostera (Zosterella) noltei bed from the southern part of the Romanian Black Sea coast, among the identified material collected in 2015, a syllid polychaete belonging to the subfamily Exogoninae, Sphaerosyllis taylori Perkins, 1981, represents a new record for the Black Sea. Re-examination of available specimens previously identified as Sphaerosyllis bulbosa Southern, 1914 revealed that they belong to an unknown species, described herein as Sphaerosyllis pontica sp. nov. The new species is characterized by the median antenna inserted more posteriorly than the lateral antennae, dorsal cirri with bulbous bases and very short tips, shorter than the parapodial lobes, dorsal cirri absent on chaetiger 2, parapodial glands with fibrillar material from chaetiger 4 onwards, compound chaetae with short blades and smooth shafts, anterior parapodia with two aciculae each, one straight and one with bent tip. Descriptions of both species are provided together with a key to all Sphaerosyllis species known from the Black Sea.